Across rheumatic diseases

Description of self-efficacy for managing symptoms and emotions in a large rheumatology clinic population

Clin Exp RheumatolPublished Retrospective cross-sectional study

Authors' conclusion

Self-efficacy is low amongst patients with rheumatologic diseases followed in a large academic centre for routine care and is highly associated with HRQoL.

Study context

Population
Patients of a large rheumatology division with office visits and completed questionnaires, May 2022 to January 2023401 (36%) with complete data
Participants
1,114 patients
Exposure
Low vs high self-efficacy for managing symptoms and emotions
Outcome
Self-efficacy (PROMIS SE Symptoms and SE Emotions) and its associations with HRQoL
Methodological detailsmultivariable linear regression
  • Multivariable linear regression

Main finding

As reported in the abstract

HRQoL (PROMIS domains)
  • Low vs high SE symptoms and SE emotions: significantly worse health-related quality of life (HRQoL) in all Patient Reported Outcome Measurement Information System (PROMIS) domains by 5-10 mean T-score units (p<0.001)
  • Strong determinants of SE Symptoms in MLR: fatigue, depression, pain interference
  • Strong determinants of SE Emotions in MLR: fatigue, anxiety, depression

Observational data: associations, not effects.

Original publication

Description of self-efficacy for managing symptoms and emotions in a large rheumatology clinic population. Clin Exp Rheumatol. Published 25 January 2024. doi:10.55563/clinexprheumatol/2dohgg

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.